65 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
distribution” cannot be offset by any net operating losses for such years, and gains (but not losses) realized on the sale of the ADSs cannot be treated
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
by BioNTech to the applicable Third Party ([***]) as an offset to the royalties payable by BioNTech to Autolus for the applicable [***] Licensed Product
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
to generate revenue from acquired technology sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition … and development expenses consist of costs incurred in connection with the research and development of our product candidates, which are partially offset
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
as a decrease in our UK reimbursable R&D tax credits claimed through the UK small and medium-size entities. These were partly offset by decreases
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
14 Mar 24
Results of Operations and Financial Condition
12:32pm
entity (SME) scheme and partially offset by decreases in clinical and manufacturing costs related to the Company’s obe-cel clinical product candidate
424B5
ycffc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
10-Q
fz2b5lgzsf8ywjp
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.3
on1s9g454 gi7jjrt
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
k238v2zti
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
b32z6spi rq8w
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.3
6g34nb zuppt3
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.3
ewmbllzlax5gha3fe0kl
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.2
y632e yybln1
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
424B5
1j3rh
9 Dec 22
Prospectus supplement for primary offering
5:40pm
6-K
EX-99.1
vcvp884 sfmkrop0x
8 Dec 22
Current report (foreign)
4:16pm
424B5
53lhgbtffvb3rw3 sw4q
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K/A
EX-99.2
1ikk3ilt4qnwm9
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.2
vb3fl3mgq
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
z6fkjub
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
6-K
EX-1
axvt6p0u3o78dkerq4
1 Jul 22
Current report (foreign)
5:15pm